Header Logo

Connection

Latania Logan to Humans

Back to Details
This is a "connection" page, showing publications Latania Logan has written about Humans.
Latania Logan
Connection Strength
0.963
Humans
  1. The role of the plasmid-mediated fluoroquinolone resistance genes as resistance mechanisms in pediatric infections due to Enterobacterales. Front Cell Infect Microbiol. 2023; 13:1249505.
    View in: PubMed
    Score: 0.048
  2. Racial, ethnic and socioeconomic disparities in SARS-CoV-2 infection amongst children. Paediatr Perinat Epidemiol. 2022 05; 36(3):337-346.
    View in: PubMed
    Score: 0.043
  3. A Previously Healthy 18-Year-Old Male With Fever, Arrhythmia, and Shock. Pediatrics. 2021 05; 147(5).
    View in: PubMed
    Score: 0.040
  4. A Multicentered Study of the Clinical and Molecular Epidemiology of TEM- and SHV-type Extended-Spectrum Beta-Lactamase Producing Enterobacterales Infections in Children. Pediatr Infect Dis J. 2021 01; 40(1):39-43.
    View in: PubMed
    Score: 0.040
  5. A Pilot Study of Chicago Waterways as Reservoirs of Multidrug-Resistant Enterobacteriaceae (MDR-Ent) in a High-Risk Region for Community-Acquired MDR-Ent Infection in Children. Antimicrob Agents Chemother. 2020 03 24; 64(4).
    View in: PubMed
    Score: 0.037
  6. Community Origins and Regional Differences Highlight Risk of Plasmid-mediated Fluoroquinolone Resistant Enterobacteriaceae Infections in Children. Pediatr Infect Dis J. 2019 06; 38(6):595-599.
    View in: PubMed
    Score: 0.035
  7. Acinetobacter baumannii Resistance Trends in Children in the United States, 1999-2012. J Pediatric Infect Dis Soc. 2019 May 11; 8(2):136-142.
    View in: PubMed
    Score: 0.035
  8. A Multi-Centered Case-Case-Control Study of Factors Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children and Young Adults. Pediatr Infect Dis J. 2019 05; 38(5):490-495.
    View in: PubMed
    Score: 0.035
  9. The Growing Threat of?Antibiotic Resistance in?Children. Infect Dis Clin North Am. 2018 03; 32(1):1-17.
    View in: PubMed
    Score: 0.032
  10. Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012. J Pediatric Infect Dis Soc. 2017 Nov 24; 6(4):352-359.
    View in: PubMed
    Score: 0.032
  11. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. J Infect Dis. 2017 Feb 15; 215(suppl_1):S28-S36.
    View in: PubMed
    Score: 0.030
  12. Ceftriaxone-Associated Biliary and Cardiopulmonary Adverse Events in Neonates: A Systematic Review of the Literature. Paediatr Drugs. 2017 Feb; 19(1):21-34.
    View in: PubMed
    Score: 0.030
  13. Raltegravir-induced drug reaction with eosinophilia and systemic symptoms syndrome in a child. Ann Allergy Asthma Immunol. 2016 Dec; 117(6):719-721.
    View in: PubMed
    Score: 0.030
  14. Analysis of ?-Lactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter Survey. Antimicrob Agents Chemother. 2016 06; 60(6):3462-9.
    View in: PubMed
    Score: 0.029
  15. Coxiella burnetii Endocarditis in a Child Caused by a New Genotype. Pediatr Infect Dis J. 2016 Feb; 35(2):213-4.
    View in: PubMed
    Score: 0.028
  16. Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012. Emerg Infect Dis. 2015 Nov; 21(11):2014-21.
    View in: PubMed
    Score: 0.028
  17. Acute necrotising ulcerative gingivitis in an immunocompromised young adult. BMJ Case Rep. 2015 Sep 16; 2015.
    View in: PubMed
    Score: 0.027
  18. Extended-spectrum ?-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat. Clin Infect Dis. 2015 May 01; 60(9):1389-97.
    View in: PubMed
    Score: 0.026
  19. Enteroviral Meningoencephalitis Complicated by Central Diabetes Insipidus in a Neonate: A Case Report and Review of the Literature. J Pediatric Infect Dis Soc. 2015 Jun; 4(2):155-8.
    View in: PubMed
    Score: 0.024
  20. A prospective cohort pilot study of the clinical and molecular epidemiology of Staphylococcus aureus in pregnant women at the time of group B streptococcal screening in a large urban medical center in Chicago, IL USA. Virulence. 2013 Oct 01; 4(7):654-8.
    View in: PubMed
    Score: 0.024
  21. Carbapenem-resistant enterobacteriaceae: an emerging problem in children. Clin Infect Dis. 2012 Sep; 55(6):852-9.
    View in: PubMed
    Score: 0.022
  22. Macrolide treatment failure in streptococcal pharyngitis resulting in acute rheumatic fever. Pediatrics. 2012 Mar; 129(3):e798-802.
    View in: PubMed
    Score: 0.021
  23. A multicenter retrospective study of childhood brucellosis in Chicago, Illinois from 1986 to 2008. Int J Infect Dis. 2011 Dec; 15(12):e812-7.
    View in: PubMed
    Score: 0.021
  24. Gemella bergeriae endocarditis in a boy. Pediatr Infect Dis J. 2008 Feb; 27(2):184-6.
    View in: PubMed
    Score: 0.016
  25. Failure to thrive in Chicago. Lancet. 2007 Jun 23; 369(9579):2132.
    View in: PubMed
    Score: 0.015
  26. Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations. Infect Control Hosp Epidemiol. 2023 01; 44(1):2-7.
    View in: PubMed
    Score: 0.011
  27. Assessing the healthcare epidemiology environment-A roadmap for SHEA's future. Infect Control Hosp Epidemiol. 2021 09; 42(9):1111-1114.
    View in: PubMed
    Score: 0.010
  28. SHEA Pediatric Leadership Council commentary: Supporting well child care during the coronavirus disease 2019 (COVID-19) pandemic with personal protective equipment in the ambulatory setting. Infect Control Hosp Epidemiol. 2021 08; 42(8):985-988.
    View in: PubMed
    Score: 0.010
  29. SHEA Pediatric Leadership Council commentary: Personal protective equipment during care of children with multisystem inflammatory syndrome in children (MIS-C). Infect Control Hosp Epidemiol. 2021 09; 42(9):1108-1110.
    View in: PubMed
    Score: 0.010
  30. SHEA Pediatric Leadership Council commentary: Inpatient visitor considerations for pediatric patients during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021 11; 42(11):1369-1371.
    View in: PubMed
    Score: 0.010
  31. SHEA Pediatric Leadership Council commentary: Ambulatory management of neonates born to mothers infected with severe acute respiratory coronavirus virus 2 (SARS-CoV-2). Infect Control Hosp Epidemiol. 2021 09; 42(9):1105-1107.
    View in: PubMed
    Score: 0.010
  32. Local, state and federal face mask mandates during the COVID-19 pandemic. Infect Control Hosp Epidemiol. 2021 04; 42(4):455-456.
    View in: PubMed
    Score: 0.010
  33. Pediatric research priorities in healthcare-associated infections and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2021 05; 42(5):519-522.
    View in: PubMed
    Score: 0.010
  34. Preparing nursing homes for a second wave of coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2021 Oct; 42(10):1251-1254.
    View in: PubMed
    Score: 0.010
  35. Organizational strategies for managing COVID-19 survivors who return for care. Infect Control Hosp Epidemiol. 2021 03; 42(3):332-333.
    View in: PubMed
    Score: 0.010
  36. Whither immunity? The search for effective, durable immunity to coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2021 Feb; 42(2):205-207.
    View in: PubMed
    Score: 0.010
  37. Notes from the Field: Candida auris and Carbapenemase-Producing Organism Prevalence in a Pediatric Hospital Providing Long-Term Transitional Care - Chicago, Illinois, 2019. MMWR Morb Mortal Wkly Rep. 2020 08 28; 69(34):1180-1181.
    View in: PubMed
    Score: 0.010
  38. The perplexing problem of persistently PCR-positive personnel. Infect Control Hosp Epidemiol. 2021 02; 42(2):203-204.
    View in: PubMed
    Score: 0.010
  39. Universal pandemic precautions-An idea ripe for the times. Infect Control Hosp Epidemiol. 2020 11; 41(11):1321-1322.
    View in: PubMed
    Score: 0.010
  40. Shifting sands-Molecular coronavirus testing during a time of inconsistent resources. Infect Control Hosp Epidemiol. 2020 10; 41(10):1190-1191.
    View in: PubMed
    Score: 0.009
  41. Variability in antimicrobial use in pediatric ventilator-associated events. Infect Control Hosp Epidemiol. 2019 01; 40(1):32-39.
    View in: PubMed
    Score: 0.009
  42. Factors Associated With Pediatric Ventilator-Associated Conditions in Six U.S. Hospitals: A Nested Case-Control Study. Pediatr Crit Care Med. 2017 Nov; 18(11):e536-e545.
    View in: PubMed
    Score: 0.008
  43. A Pediatric Approach to Ventilator-Associated Events Surveillance. Infect Control Hosp Epidemiol. 2017 03; 38(3):327-333.
    View in: PubMed
    Score: 0.007
  44. First Report of a Verona Integron-Encoded Metallo-?-Lactamase-Producing Klebsiella pneumoniae Infection in a Child in the United States. J Pediatric Infect Dis Soc. 2016 Sep; 5(3):e24-7.
    View in: PubMed
    Score: 0.007
  45. The Prevalence and Molecular Epidemiology of Multidrug-Resistant Enterobacteriaceae Colonization in a Pediatric Intensive Care Unit. Infect Control Hosp Epidemiol. 2016 May; 37(5):535-43.
    View in: PubMed
    Score: 0.007
  46. Ventilator-Associated Events in Neonates and Children--A New Paradigm. Crit Care Med. 2016 Jan; 44(1):14-22.
    View in: PubMed
    Score: 0.007
  47. Regional Epidemiology of Methicillin-Resistant Staphylococcus aureus Among Critically Ill Children in a State With Mandated Active Surveillance. J Pediatric Infect Dis Soc. 2016 Dec; 5(4):409-416.
    View in: PubMed
    Score: 0.007
  48. Persistent Pneumonia in an Infant. Pediatrics. 2015 Jul; 136(1):154-60.
    View in: PubMed
    Score: 0.007
  49. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia. mBio. 2014 Jun 10; 5(3):e01080-14.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.